// App-Quantinova.ai

15355 : Interleukin-1beta Inhibition Attenuates Accelerated Atherosclerosis in Mice With Tet2 Loss of Function in a Sex-dependent Fashion

Researchers

Presenter

  • Amelie Vromman

Principal Investigators

  • Mariana Janini Gomes

  • Victoria Ruvkun

  • Eugenia Shvartz

  • Eva Kritikou

  • Paul Carter

  • Samuel Moscavitch

  • Tetsushi Nakao

  • Rob Sellar

  • Marie McConkey

  • Grasiele Sausen

  • Waihay Wong

  • Yevgenia Tesmenitsky

  • Shah Kavi

  • Andrew H Lichtman

  • Benjamin Ebert

  • Galina K Sukhova

  • Rajat Gupta

  • Peter Libby

Medical Centers

  • Cardiovascular Medicine, Brigham & Womens Hosp, Boston, MA

  • Broad Institute, Cambridge, MA

  • Brigham and Women's Hospital, Brookline, MA

  • Cambridge, United Kingdom

  • Kings College London, London, United Kingdom

  • Dana-Farber Cancer Institute, Boston, MA

  • Brigham & Women's Hospital, Boston, MA

  • Dana-Farber Cancer Institute, Boston, MA

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Atherosclerotic lesions

  • Coronary Artery Disease

Biomarkers

  • Interleukin 1 beta

Drug/Treatment

  • Interleukin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved